Casdin Capital, LLC Magenta Therapeutics, Inc. Transaction History

Casdin Capital, LLC

$1.29 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $2.64 Million - $4.38 Million	-2,095,000 Reduced 86.75%	320,000 $451,000
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $347,713 - $1.1 Million	-358,468 Reduced 12.92%	2,415,000 $2.9 Million
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $2.88 Million - $5.9 Million	-1,128,121 Reduced 28.91%	2,773,468 $8.04 Million
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $3.37 Million - $5.49 Million	555,555 Added 16.6%	3,901,589 $28.4 Million
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $2.32 Million - $4.04 Million	375,000 Added 12.62%	3,346,034 $25.1 Million
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $766,334 - $1.94 Million	-127,087 Reduced 4.1%	2,971,034 $18.7 Million
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $453,500 - $792,000	50,000 Added 1.64%	3,098,121 $47 Million
Q3 2019 Nov 12, 2019	SELL	$9.63 - $14.0 $28.9 Million - $42 Million	-3,003,121 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$9.63 - $14.0 $29.4 Million - $42.7 Million	3,048,121 New	3,048,121 $31.3 Billion
Q2 2019 Aug 13, 2019	BUY	$13.4 - $17.67 $4.82 Million - $6.36 Million	359,803 Added 13.61%	3,003,121 $0
Q1 2019 May 15, 2019	BUY	$5.7 - $19.7 $5 - $19	1 Added 0.0%	2,643,318 $43.5 Million
Q4 2018 Feb 13, 2019	BUY	$5.57 - $11.65 $2.19 Million - $4.57 Million	392,499 Added 17.44%	2,643,317 $15.1 Million
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $2.43 Million - $3.38 Million	215,000 Added 10.56%	2,250,818 $27 Million
Q2 2018 Aug 20, 2018	BUY	$13.5 - $14.52 $22.1 Million - $23.8 Million	1,635,818 Added 408.95%	2,035,818 $27.5 Million
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $5.4 Million - $5.81 Million	400,000 New	400,000 $5.4 Million

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account